{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:01:48Z","timestamp":1773324108274,"version":"3.50.1"},"reference-count":0,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"47","license":[{"start":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T00:00:00Z","timestamp":1290643200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,25]]},"abstract":"<jats:p>Neisseria gonorrhoeae has developed resistance to most of the available therapeutic antimicrobials. The susceptibility to extended-spectrum cephalosporins, the last remaining first-line treatment option, is decreasing globally. This report describes the first two cases outside Japan of verified gonorrhoea clinical failures using internationally recommended first-line cefixime treatment. Enhanced awareness and more frequent follow-up examination, test-of-cure and appropriate verification\/falsification of presumed clinical treatment failures, involving several clinical and laboratory parameters should be strongly emphasised worldwide. \n<\/jats:p>","DOI":"10.2807\/ese.15.47.19721-en","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T11:55:21Z","timestamp":1511870121000},"update-policy":"https:\/\/doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":119,"title":["Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010"],"prefix":"10.2807","volume":"15","author":[{"given":"M","family":"Unemo","sequence":"first","affiliation":[{"name":"Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, \u00d6rebro University Hospital, \u00d6rebro, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Golparian","sequence":"additional","affiliation":[{"name":"Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, \u00d6rebro University Hospital, \u00d6rebro, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Syversen","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Oslo University Hospital, Ullev\u00e5l, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D F","family":"Vestrheim","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Olafiaklinikken, Oslo University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Moi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Oslo, Oslo, Norway"},{"name":"Olafiaklinikken, Oslo University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7995","container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T12:28:51Z","timestamp":1663244931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/ese.15.47.19721-en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,25]]},"references-count":0,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2010,11,25]]}},"URL":"https:\/\/doi.org\/10.2807\/ese.15.47.19721-en","relation":{},"ISSN":["1560-7917"],"issn-type":[{"value":"1560-7917","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,25]]}}}